Collections

  • Collection |

    This Collection highlights the newest top-viewed content from Eye. Updated each month, we hope you enjoy reading this curated list of recent research. Eye aims to publish the latest developments in clinical and laboratory-based research, to provide practicing clinicians, healthcare workers and researchers with information on the latest developments in ophthalmology.

    Image: Evi Scholz / EyeEm; Science Photo Library - PASIEKA; Emiliano Orsi / EyeEm
  • Collection |

    Cochrane Eyes and Vision (CEV) is an international network of individuals working to prepare, maintain and promote access to systematic reviews of interventions and diagnostic tests to diagnose, treat or prevent eye diseases or visual impairment (https://eyes.cochrane.org/) . CEV has teamed up with Eye to produce clinical commentaries on selected Cochrane Reviews.

  • Collection |

    Should ophthlamologists be wearing a mask in clinic? Does the slit-lamp shield provide adequate protection? How to continue research work during the COVID-19 pandemic? These are important questions many of us ask on a daily basis. This Eye collection will focus on the latest evidence and impact of COVID-19 on Ophthalmology practice. Several articles in this issue will discuss the latest understanding of ocular involvement by coronavirus and the risk of transmission through ocular tissue and tears. Ophthalmologists from different parts of the world including the UK, France, Italy and Asia will share their experiences regarding how their practices have had to reorganize to the evolving situation. Read this informative COVID-EYE Edition, and you will learn practical tips on how to adapt your daily practice to this challenging crisis.

    Image: Radoslav Zilinsky/ Moment/ Getty
  • Collection |

    The Editors of Eye and Gene Therapy have put together this joint collection on gene therapy in the eye, to showcase some of the recent research in this field.

    Image: Yuichiro Chino
  • Special |

    This is a special issue in a special year when we will reflect on the achievements (and challenges) of VISION 2020, a global WHO initiative that aimed to eliminate avoidable blindness. Much progress has been done to improve health outcomes in people with glaucoma but it is humbling to reflect on the burden of glaucoma, still a leading cause of blindness in the developed world and much of it preventable. The challenge of preventing blindness and providing glaucoma care in low-to-middle outcome countries are gigantic. In this special issue we have included some of the most relevant and exciting developments both in translational and clinical research. The efforts of many talented and dedicated individuals and organisations working towards prevention and treatment of glaucoma will continue to make a difference. We would like to thank all authors for their generous contributions. Anthony Khawaja and Augusto Azuara-Blanco

  • Collection |

    This collection highlights some of Eye’s published content contributed by authors from the US. Covering a range of topics on various fields within Ophthalmology, this Collection was curated by Eye’s Editor-in-Chief, Sobha Sivaprasad, and includes a selection of reviews and original research. Some of the reviews succinctly cover a large topic of interest while others provide perspectives on novel research areas or controversies. Original articles demonstrate diverse advances in research on disease mechanisms, therapeutics and basic science. The collection also includes an interesting article on Eponymous women in ophthalmology, emphasising syndromes with prominent eye manifestations named after female physicians!

    Image: © Rawf8 / stock.adobe.com
  • Special |

    This collection provides a wide spectrum of reviews on prevalent eye conditions in Asia. Areas of focus include new insights on Pachychoroid, the much awaited role of artificial intelligence in the screening of diabetic retinopathy, control of myopia, acute angle closure glaucoma and infectious and non-infectious disease of particular relevance in Asia.

  • Focus |

    Intravitreal Avastin - is it unlicensed, off-label, unlawful or cheap?

    Image: Evi Scholz / EyeEm; Science Photo Library - PASIEKA; Emiliano Orsi / EyeEm